UPDATE : Wednesday, June 26, 2019
상단여백
‘Medytox got review suspension in China only once’
Korean botulinum toxin maker Medytox said the Chinese regulator ordered the...
by Jeong Sae-im  |  2019-06-11 10:50
라인
[ASCO 2019] Imfinzi 1st IO to report 3-year OS in unresectable stage III NSCLC
Chicago, Ill -- AstraZeneca‘s Imfinzi (Ingredient: durvalumab) has demonstr...
by Lee Han-soo, KBR Correspondent  |  2019-06-11 08:00
라인
SCM, T&R to develop tissue regeneration, therapy products
SCM Life Science and T&R Biofab have agreed to collaborate on the research ...
by Lee Han-soo  |  2019-06-10 17:50
라인
Regulator OKs AstraZeneca's Fasenra as additional therapy for severe asthma
AstraZeneca's Fasenra (ingredient: benralizumab) gained approval as an ...
by Lee Han-soo  |  2019-06-10 17:10
라인
CJ HealthCare to invest ₩100 billion in new IV fluid factory
CJ HealthCare, a subsidiary of Kolmar Korea, said Monday it would invest 10...
by Jeong Sae-im  |  2019-06-10 16:17
라인
'Big data is overrated, vulnerable to contamination'
Big data, the key to medical technologies in the future, is being regarded ...
by Kim Eun-young  |  2019-06-10 16:15
라인
Hanmi unveils strong pipeline candidates in US diabetes meet
Hanmi Pharmaceutical said that it has confirmed its global competitiveness ...
by Lee Han-soo  |  2019-06-10 15:07
라인
Medytox’ botulinum toxin may face approval delay in China
Korean botulinum toxin maker Medytox may likely suffer a delay in Chinese r...
by Jeong Sae-im  |  2019-06-10 13:55
라인
State health insurance agency, WHO seeks cooperation
National Health Insurance Service (NHIS) President Kim Yong-ik held talks w...
by Kim Eun-young  |  2019-06-07 16:27
라인
Kolon TissueGene CEO resigns
Kolon TissueGene, a subsidiary of Kolon Life Science, said Co-CEO Lee Woo-s...
by Jeong Sae-im  |  2019-06-07 15:35
라인
Expat workers left behind in mandatory health insurance program
Foreigners who stay longer than six months in Korea are obliged to subscrib...
by Kim Eun-young  |  2019-06-07 15:27
라인
Patient Revolution author admits license revocation on Facebook
Joshua Cho, the author of the popular healthcare book “Patient Revolution,”...
by Song Soo-youn  |  2019-06-07 14:58
라인
Daewoong joins fray to develop rheumatoid arthritis drug
Daewoong Pharmaceutical said it has begun developing a rheumatoid arthritis...
by Lee Hye-seon  |  2019-06-07 11:29
라인
Ilsan Hospital succeeds in single-port retroperitoneal renal tumor resection
NHIS (National Health Insurance Service) Ilsan Hospital said it has success...
by Song Soo-youn  |  2019-06-05 16:14
라인
Korea’s hospital information system launched at 4th US hospital
A Korean hospital information system called “Best Care 2.0B,” developed by ...
by Choi Gwang-seok  |  2019-06-05 14:59
라인
Pharma industry urges deregulation to develop new drug using AI
The Korean pharmaceutical industry called for the government to ease regula...
by Jeong Sae-im  |  2019-06-05 11:53
라인
[ASCO 2019] 'Ibrance brings hopes to neglected premenopausal breast cancer patients'
CHICAGO, Ill. -- A Korean study has shown that Pfizer's Ibrance extends...
by Lee Han-soo, KBR Corresponden  |  2019-06-05 11:33
라인
[ASCO 2019]'Belvarafenib confirms efficacy for solid cancer without approved treatment'
CHICAGO, Ill. -- Belvarafenib, developed by Hanmi Pharmaceutical, has demon...
by Lee Han-soo, KBR Correspondent  |  2019-06-05 11:29
라인
Seoul holds policy consultation with WHO
The Ministry of Health and Welfare and the delegation from the World Health...
by Kwak Sung-sun  |  2019-06-04 17:35
라인
8 out of 10 Korean doctors wish to leave the country
Eight out of 10 doctors in Korea want to leave for another country to work ...
by Song Soo-youn  |  2019-06-04 15:28
여백
여백
여백
Back to Top